Who owns Outlook Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of OTLK from SEC Form 13F filings across 71 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 71 institutions disclosed 20.3M shares of Outlook Therapeutics, Inc. worth $30.9M — about 14.8% of shares outstanding; the largest disclosed holder is VANGUARD CAPITAL MANAGEMENT LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
71
13F holders
$30.9M
value, 2026 filers
14.8%
of shares outstanding (20.3M sh)
32
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of OTLK's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 4.4M | $7.0M | 0.0% | 3.2% | +122.5% |
| 2 | PERCEPTIVE ADVISORS LLCNEW | 3.1M | $5.0M | 0.1% | 2.3% | new |
| 3 | MARSHALL WACE, LLPNEW | 2.0M | $3.2M | 0.0% | 1.5% | new |
| 4 | BlackRock, Inc. | 1.7M | $2.7M | 0.0% | 1.2% | +249.5% |
| 5 | JANE STREET GROUP, LLCNEW | 1.4M | $2.3M | 0.0% | 1% | new |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 1.2M | $2.0M | 0.0% | 0.9% | +106.4% |
| 7 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 968,190 | $1.5M | 0.0% | 0.7% | +622.1% |
| 8 | HRT FINANCIAL LP | 784,904 | $1,247 | 0.0% | 0.6% | +1058.4% |
| 9 | VANGUARD FIDUCIARY TRUST CO | 661,664 | $1.1M | 0.0% | 0.5% | +274.8% |
| 10 | GILPIN WEALTH MANAGEMENT, LLC | 555,000 | $882,450 | 0.6% | 0.4% | -7.5% |
| 11 | STATE STREET CORP | 539,802 | $858,285 | 0.0% | 0.4% | +231.0% |
| 12 | Sanctuary Advisors, LLCNEW | 344,529 | $547,801 | 0.0% | 0.3% | new |
| 13 | RAYMOND JAMES FINANCIAL INC | 332,051 | $527,961 | 0.0% | 0.2% | +1127.5% |
| 14 | GROUP ONE TRADING LLC | 246,428 | $391,821 | 0.0% | 0.2% | +116.7% |
| 15 | NORTHERN TRUST CORP | 237,561 | $377,722 | 0.0% | 0.2% | +252.5% |
| 16 | CANTOR FITZGERALD, L. P.NEW | 225,000 | $357,750 | 0.0% | 0.2% | new |
| 17 | SIMPLEX TRADING, LLC | 205,013 | $325,970 | 0.0% | 0.1% | +54.5% |
| 18 | LPL Financial LLC | 184,942 | $294,058 | 0.0% | 0.1% | +450.0% |
| 19 | UBS Group AG | 152,215 | $242,022 | 0.0% | 0.1% | +14.4% |
| 20 | DEUTSCHE BANK AG\NEW | 130,700 | $207,813 | 0.0% | 0.1% | new |
| 21 | Wealth Management Partners, LLCNEW | 118,170 | $187,890 | 0.0% | 0.1% | new |
| 22 | Jefferies Financial Group Inc.NEW | 62,500 | $99,375 | 0.0% | 0% | new |
| 23 | MILLENNIUM MANAGEMENT LLCNEW | 57,839 | $91,964 | 0.0% | 0% | new |
| 24 | Tower Research Capital LLC (TRC) | 57,391 | $91,252 | 0.0% | 0% | +287.6% |
| 25 | Royal Fund Management, LLCNEW | 47,200 | $75,048 | 0.0% | 0% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.